| US 12,439,945 |
Method of improving flavor of a composition of (D)-β-hydroxybutyric acid and (D)-1,3 butanediol, and use as a nutritional supplement and therapeutic agent |
Flavor |
13 May 2024 |
14 Oct 2025expires 4 Mar 2041 |
Granted |
| US 11,985,999 |
Method of improving flavor of a composition of (D)-β-hydroxybutyric acid and (D)-1,3 butanediol, and use as a nutritional supplement and therapeutic agent |
Flavor |
11 Oct 2021 |
21 May 2024expires 5 Sep 2041 |
Granted |
| US 11,141,392 |
Method of improving flavor of a composition of (D)-β-hydroxybutyric acid and (D)-1,3 butanediol, and use as a nutritional supplement and therapeutic agent |
Flavor |
4 Mar 2021 |
12 Oct 2021expires 4 Mar 2041 |
Granted |
| US 11,044,932 |
Composition of (D)-β-hydroxybutyric acid, (D)-β-hydroxyvaleric acid, and (D)-1,3 butanediol |
Composition |
4 Mar 2021 |
29 Jun 2021expires 4 Mar 2041 |
Granted |
| US 2026/0047591 |
Method of improving flavor of a composition of (D)-β-hydroxybutyric acid and (D)-1,3 butanediol, and use as a nutritional supplement and therapeutic agent |
Flavor |
29 Sep 2025 |
19 Feb 2026 |
Pending |
| US 2024/0368644 |
Methods to produce therapeutic formulations comprising hydroxybutyrate and hydroxyvalerate, therapeutic formulations, and uses thereof |
Production |
23 Jun 2022 |
7 Nov 2024co-owned with PHB Industrial S.A. |
Pending |
| US 2023/0079812 |
Composition of (D)-β-hydroxybutyric acid, (D)-1,3 butanediol, and digestible carbohydrate |
Composition |
27 Oct 2022 |
16 Mar 2023 |
Pending |
| EP 4 363 599 |
Methods to produce therapeutic formulations comprising hydroxybutyrate and hydroxyvalerate |
Production |
23 Jun 2022 |
8 May 2024co-owned with PHB Industrial S.A. |
Pending |
| CA 3,223,325 |
Methods to produce therapeutic formulations comprising hydroxybutyrate and hydroxyvalerate |
Production |
23 Jun 2022 |
5 Jan 2023co-owned with PHB Industrial S.A. |
Pending |
| BR 11 2023 024355 |
Process for producing optically active mixtures of (R)-3-hydroxybutyrate and (R)-3-hydroxyvalerate |
Production |
23 Jun 2022 |
6 Feb 2024co-owned with PHB Industrial S.A. |
National phase |
| WO 2023/278240 |
Methods to produce therapeutic formulations comprising hydroxybutyrate and hydroxyvalerate |
Production |
23 Jun 2022 |
5 Jan 2023national phase entered |
PCT, superseded |
| US 2024/0292876 |
Method of improving flavor of a composition of (D)-β-hydroxybutyric acid and (D)-1,3 butanediol, and use as a nutritional supplement and therapeutic agent |
Flavor |
13 May 2024 |
5 Sep 2024 |
Issued as 12,439,945 |
| US 2022/0095664 |
Method of improving flavor of a composition of (D)-β-hydroxybutyric acid and (D)-1,3 butanediol, and use as a nutritional supplement and therapeutic agent |
Flavor |
11 Oct 2021 |
31 Mar 2022 |
Issued as 11,985,999 |
| US 2021/0275474 |
Method of improving flavor of a composition of (D)-β-hydroxybutyric acid and (D)-1,3 butanediol, and use as a nutritional supplement and therapeutic agent |
Flavor |
4 Mar 2021 |
9 Sep 2021 |
Issued as 11,141,392 |
| US 2021/0322349 |
Composition of (D)-β-hydroxybutyric acid, (D)-β-hydroxyvaleric acid, and (D)-1,3 butanediol |
Composition |
28 Jun 2021 |
21 Oct 2021continued as 2023/0079812 |
Abandoned |